Study shows association of PR status with response to progestin-based therapy in endometriosis
Progesterone receptor (PR) status, as determined by the Histo (H)-score, is strongly associated with response to progestin-based therapy in endometriosis, says a study reported in the Journal of Clinical Endocrinology & Metabolism, online October 23, 2018. The study further says that receptor status in endometriosis could be used to tailor hormonal-based regimens after surgery and negate trialing progestin-based therapy to determine resistance.
To continue reading this article
Continue reading your article with a eMediNexus account.